Come and meet Acticor Biotech, represented by Gilles Avenard - our CEO and Sophie Binay, PhD - our General Manager and CSO, at Investir Day!
After the recent IPO of the company, they will present the developments of glenzocimab in the treatment of ischemic stroke.
